Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
A risk factor is anything that changes your chance of getting a disease like cancer. Different cancers have different risk factors. For example, unprotected exposure to strong sunlight is a risk factor for skin cancer. Smoking is a risk factor for cancers of the lung, and many other cancers. But risk factors don’t tell us everything. Having a risk factor, or even many, doesn’t mean that you will get the cancer. Also, many people get cancer without having a risk factor.
Injury and lifestyle factors such as smoking, diet, and exercise are NOT linked to the risk for soft tissue sarcoma . But the injury issue has caused some confusion in the past. One reason is that an injured area might swell. That swelling could look like a tumor, but it isn't one. Also, when you are injured, the pain may draw your attention to the injured area. A doctor may check the area, and x-rays or other imaging studies may be done. This can make it more likely that any sarcoma that's there will be discovered, even though it may have been there for some time.
Still, scientists have found a few risk factors that make a person more likely to develop soft tissue sarcomas:
Radiation exposure accounts for less than 5% of sarcomas. But patients might develop sarcomas from radiation given to treat other cancers, like breast cancer or lymphoma . The sarcoma often starts in the part of the body that was treated with radiation. The average time between the radiation treatments and the diagnosis of a sarcoma is about 10 years.
Radiation therapy techniques have improved steadily over several decades. Treatments now target cancers more precisely, and more is known about selecting radiation doses. These advances are expected to reduce the number of cancers caused by radiation therapy. But because these cancers take so long to develop, the results of these changes may not be seen for a long time. Still, radiation therapy is used only when its benefits (improved survival rate and relief of symptoms) outweigh its risks . To learn more, see Second Cancers in Adults.
Family cancer syndromes are disorders caused by gene defects (mutations) that people are born with (often inherited from a parent) that are linked to a high risk of getting certain cancers. Some family cancer syndromes increase a person's risk of developing soft tissue sarcomas.
Neurofibromatosis is also known as von Recklinghausen disease. It usually runs in families and causes many benign (not cancer) tumors that form in nerves under the skin and in other parts of the body (These are called neurofibromas.) It's caused by a defect (mutation) in genes called NF1 and NF2. About 5% of people with neurofibromatosis will develop a sarcoma in a neurofibroma.
Gardner syndrome is a disease caused by defects in the APC gene. This syndrome is a type of familial adenomatous polyposis (FAP), and people with it get many polyps in the colon (and intestines) and have a high risk of getting colon cancer . It also causes problems outside the colon, including desmoid tumors. (These are discussed in What Is a Soft Tissue Sarcoma? )
Li-Fraumeni syndrome is caused by inherited defects in the TP53 gene. People affected by this syndrome have a high risk of cancer, such as breast cancer, brain tumors, leukemia , and sarcomas. Still, only 10 to 20 out of 100 people with Li-Fraumeni syndrome will develop a soft tissue sarcoma. People with this syndrome are sensitive to the cancer-causing effects of radiation. So if they have a cancer that's treated with radiation, they have a very high chance of developing a new cancer in the part of the body that was treated.
Retinoblastoma is an eye cancer in children that can be caused by defects in the RB1 gene. Children with this gene defect also have a higher risk of developing bone or soft tissue sarcomas, especially if the retinoblastoma was treated with radiation.
Werner syndrome is caused by defects in the RECQL2 gene. Children with this syndrome have problems like those seen in the elderly. These include cataracts, skin changes, and clogged heart arteries (arteriosclerosis) which can lead to heart attacks. They also have an increased risk of cancer, including soft tissue sarcomas.
Gorlin syndrome is also called nevoid basal cell carcinoma syndrome (NBCCS). It's caused by defects in the PTCH1 gene. People with this syndrome have a high risk of developing many basal cell skin cancers. They also have an increased risk of fibrosarcoma and rhabdomyosarcoma.
Tuberous sclerosis can be caused by a defect in the TSC1 and/or TSC2 gene. People with this syndrome often have seizures and learning problems. They get benign (not cancer) tumors in many different organs. They also have kidney problems, often along with a kidney tumor called angiomyolipoma. People with tuberous sclerosis have an increased risk of rhabdomyosarcoma.
Lymph is a clear fluid containing immune system cells that's carried throughout the body by a series of lymph vessels. These vessels connect lymph nodes (small bean-shaped collections of immune system cells). When lymph nodes have been removed or damaged by radiation therapy, lymph fluid can build up and cause swelling. This is called lymphedema.
Lymphangiosarcoma (a malignant (cancer) tumor that develops in lymph vessels) is a very rare complication of chronic lymphedema.
Exposure to vinyl chloride (a chemical used in making plastics) is a risk factor for developing sarcomas of the liver, but it hasn't been proven to cause soft tissue sarcomas. Arsenic has also been linked to a type of liver sarcoma but not soft tissue sarcoma. Exposure to dioxin and to herbicides that contain phenoxyacetic acid at high doses (such as might occur in people who work on farms) may also be risk factors, but this isn't known for certain. There's no evidence that herbicides (weed killers) or insecticides, at levels encountered by the general public, cause sarcomas.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
American Society of Clinical Oncology. Nevoid Basal Cell Carcinoma Syndrome. 04/2016. Accessed at www.cancer.net/cancer-types/nevoid-basal-cell-carcinoma-syndrome on March 27, 2018.
American Society of Clinical Oncology. Sarcoma, Soft Tissue: Risk Factors. 08/2017. Accessed at www.cancer.net/cancer-types/sarcoma-soft-tissue/risk-factors on March 27, 2018.
American Society of Clinical Oncology. Tuberous Sclerosis Complex. 11/2016. Accessed at www.cancer.net/cancer-types/tuberous-sclerosis-complex on March 27, 2018.
American Society of Clinical Oncology. Werner Syndrome. 12/20167. Accessed at www.cancer.net/cancer-types/werner-syndrome on March 27, 2018.
European Society for Medical Oncology. Soft Tissue Sarcomas: A Guide for Patients. 2106. Accessed at http://www.esmo.org/content/download/75509/1380040/file/ESMO-ACF-Soft-Tissue-Sarcomas-Guide-for-Patients.pdf on March 27, 2017.
Helman LJ, Maki RG. Sarcomas of soft tissue. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Abeloff‘s Clinical Oncology. 5th ed. Philadelphia, PA. Elsevier: 2014: 1753-1791.
National Cancer Institute. Adult Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version. February 1, 2018. Accessed at www.cancer.gov/types/soft-tissue-sarcoma/hp/adult-soft-tissue-treatment-pdq on March 27, 2018.
National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Soft Tissue Sarcoma, Version 1.2018 -- October 31, 2017. Accessed at www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf on March 27, 2018.
Singer S, Maki R, O’Sullivan B. Soft tissue sarcoma In: DeVita VT, Heilman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:1533-1577.
Last Revised: April 6, 2018